Nobel Prize in medicine honors 2 Massachusetts researchers for microRNA discovery
STOCKHOLM - Two researchers working in Massachusetts have been awarded the Nobel Prize in medicine.
MicroRNA
American professors Victor Ambros and Gary Ruvkun were honored Monday for their discovery of microRNA, tiny pieces of genetic material that alter how genes work at the cellular level and could lead to new ways of treating cancer.
The Nobel Assembly said that their discovery is "proving to be fundamentally important for how organisms develop and function."
Victor Ambros
Ambros performed the research that led to his prize at Harvard University.
He is currently a professor of natural science at the University of Massachusetts Medical School in Worcester. Ambros was born in Hanover, New Hampshire. He earned his PhD from the Massachusetts Institute of Technology (MIT) in 1979.
Ambros wasn't awake when the call came from Sweden around 4:30 a.m. Massachusetts time.
"Somebody called my son, who called my wife as my phone was downstairs," he said.
Gary Ruvkun
Ruvkin's research was performed at Massachusetts General Hospital and the Harvard Medical School, where he's a professor of genetics. Ruvkin was born in Berkeley, California. He earned his PhD from Harvard in 1982.
Thomas Perlmann, Secretary-General of the Nobel Committee, said he spoke to Ruvkun on the phone shortly before the announcement early Monday morning.
"It took a long time before he came to the phone and sounded very tired, but he quite rapidly was quite excited and happy, when he understood what it was all about," Perlmann said.
"Well, when a phone rings at 4:30 in the morning. ... It never happens here," Ruvkun said.
"Natasha actually answered it," Ruvkun added, referring to his wife. "And she goes: 'He has a Swedish accent.'"
Ruvkun knew immediately the impact the award would have on his life.
"Well, I just kept repeating in my mind, this changes everything because you know, the Nobel is just mythic in how it transforms the life of people who are selected," Ruvkun said. "The Nobel Prize is a recognition that's sort of 100 times as much press and celebration as any other award. So, it's not part of a continuum. It's a quantum leap."
What is microRNA?
Ambros and Ruvkun, the assembly explained, were initially interested in genes that control the timing of different genetic developments, ensuring that cell types develop at the right time.
To do that, they studied two mutant strains of worms commonly used as research models in science. The two scientists set out to identify the mutated genes responsible in these worms and what their role was. The mechanism they ultimately identified - the regulation of genes by microRNA - has allowed organisms to evolve for hundreds of millions of years.
The Nobel committee said Ambros and Ruvkun's discovery ultimately "revealed a new dimension to gene regulation, essential for all complex life forms."
MicroRNA have opened up scientists' approaches to treating diseases like cancer by helping to regulate how genes work at the cellular level, according to Dr. Claire Fletcher, a lecturer in molecular oncology at Imperial College London.
Fletcher said there were two main areas where microRNA could be helpful: in developing drugs to treat diseases and in serving as possible indicators of diseases, by tracking microRNA levels in the body.
"If we take the example of cancer, we'll have a particular gene working overtime, it might be mutated and working in overdrive," she said. "We can take a microRNA that we know alters the activity of that gene and we can deliver that particular microRNA to cancer cells to stop that mutated gene from having its effect."
Fletcher said there are clinical trials ongoing to see how microRNA approaches might help treat skin cancer, but that there aren't yet any drug treatments approved by drug regulators. She expected that might happen in the next five to 10 years.
She said microRNA represent another way of being able to control the behavior of genes to treat and track various diseases.
"The majority of therapies we have at the moment are targeting proteins in cells," she said. "If we can intervene at the microRNA level, it opens up a whole new way of us developing medicines and us controlling the activity of genes whose levels might be altered in diseases."
Nobel Prizes
Last year, the Nobel Prize in Physiology or Medicine went to Hungarian-American Katalin Karikó and American Drew Weissman for discoveries that enabled the creation of mRNA vaccines against COVID-19 that were critical in slowing the pandemic.
The prize carries a cash award of $1 million from a bequest left by the prize's creator, Swedish inventor Alfred Nobel.
The announcement launched this year's Nobel prizes award season.
Nobel announcements continue with the physics prize on Tuesday, chemistry on Wednesday and literature on Thursday. The Nobel Peace Prize will be announced Friday and the Nobel Memorial Prize in Economic Sciences on Oct. 14.
The laureates are invited to receive their awards at ceremonies on Dec. 10, the anniversary of Nobel's death.
Associated Press writers Daniel Niemann, Maria Cheng and Mike Corder contributed to this report.